Profile Analiza SWOT

Embed Size (px)

Citation preview

  • 7/30/2019 Profile Analiza SWOT

    1/6

    Main contactDr. LUIS MENENDEZ-ARIASOrganisation name: Centro de Biologa Molecular Severo Ochoa (CSIC-UAM)

    http://www.cbm.uam.esDepartment/Unit: Virology and MicrobiologyAddress: c/ Nicols Cabrera, 128049 Madrid Spain

    Main organisationCentro de Biologa Molecular Severo Ochoa (CSIC-UAM)Address: c/ Nicols Cabrera, 128049 Madrid Spain

    ExpertiseFavourite themeFP7-PEOPLE, FP7-HEALTH, FP7-INCOExpertise descriptionResearch in the laboratory of Dr. Menendez-Arias is mainly devoted tounderstanding structure-activity relationships in human immunodeficiencyvirus type 1 (HIV-1) reverse transcriptase (RT), elucidating mechanisms ofHIV-1 resistance to antiretroviral drugs, and understanding HIV replicationfitness. The group has experience in the characterization of viral enzymesand is potentially interested in the purification and characterization of viralpolymerases. Molecular biology techniques (e.g. cloning, site-directedmutagenesis, RT-PCR amplifications, etc...) and protein expression andpurification are commonly used in the lab of the group leader. In addition,the lab has a strong background in using more specialized methods inenzymology, such as pre-steady-state kinetics of nucleotide incorporation.We would be interested in collaborating in projects dealing with thecharacterization of viral polymerases and eventually identification of potentialantiviral drugs.Expertise categories

    Medicine, Health, Biotechnology, Life sciences, Medical biotechnology,Coordination, Cooperation, Scientific researchSkills and competencesDr. Luis Menndez-Arias is a Research Professor of the Consejo Superior deInvestigaciones Cientficas (CSIC, Spanish National Research Council) andGroup Leader at the CBMSO, where he has been working since 1994. Hisresearch is mainly devoted to understanding structure-activity relationshipsin human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),

    http://www.cbm.uam.es/https://cordis.europa.eu/partners/web/lmenendezarias/profile?p_p_id=3&p_p_lifecycle=0&p_p_state=maximized&p_p_mode=view&p_p_col_id=public-column-2&p_p_col_count=2&_3_orgName=Centro+de+Biolog%C3%ADa+Molecular+Severo+Ochoa+(CSIC-UAM)&_3_struts_action=%2Fsearch%2Fsearch&_3_searchtype=advSearchhttps://cordis.europa.eu/partners/web/lmenendezarias/profile?p_p_id=3&p_p_lifecycle=0&p_p_state=maximized&p_p_mode=view&p_p_col_id=public-column-2&p_p_col_count=2&_3_orgName=Centro+de+Biolog%C3%ADa+Molecular+Severo+Ochoa+(CSIC-UAM)&_3_struts_action=%2Fsearch%2Fsearch&_3_searchtype=advSearchhttp://www.cbm.uam.es/
  • 7/30/2019 Profile Analiza SWOT

    2/6

    elucidating mechanisms of HIV-1 resistance to antiretroviral drugs, andunderstanding HIV replication fitness. Dr. Menndez-Arias graduated fromthe Complutense University of Madrid, Spain in Biology in 1984, and obtainedhis Ph.D. in 1989 at the Department of Biochemistry and Molecular Biology ofthe Faculties of Biology and Chemistry of the same university. Between 1990

    and 1994, he was trained as a postdoctoral fellow in the Frederick CancerResearch and Development Center, Frederick, Maryland, USA, where heconducted studies on the biochemical properties of retroviral proteases andtheir implications in virus maturation and antiviral therapy. He has published86 papers listed in PubMed (his h index is 26).At present, he is Academic Editor of the journals Sequencing and PLoS ONE,and member of the Editorial Boards of Antiviral Research, Antiviral Therapy,Virus Research, Viruses and World Journal of Virology. He also served asguest editor for special issues of the journals Virus Research (Retroviralreverse transcription, co-edited with Dr. B. Berkhout and published in 2008)and Viruses (Retroviral enzymes, published in 2010). At present, Dr.Menndez-Arias leads a group of 6 people with two post-docs and two Ph.D.students, as well as a visiting Masters degree student from the University ofParma. He is also involved in teaching activities of Master degrees at themajor universities of Madrid.Research infrastructure of the organisationThe Centro de Biologa Molecular Severo Ochoa is a biological researchcentre founded in 1975 as a joint venture of the Universidad Autnoma deMadrid (UAM) and the Consejo Superior de Investigaciones Cientficas (CSIC,Spanish National Research Council). Research at CBMSO covers a widevariety of topics in molecular biology. At present, the institute is housed in

    new facilities inaugurated in January 2008. The Institute employs more than600 people (about 100 senior scientists/permanent staff). The CBMSO isorganized in five research departments (Cellular Biology and Immunology,Virology and Microbiology, Genome Function and Dynamics, MolecularNeurobiology and Development and Differentiation) and has a number ofcore facilities that constitute the Technical Department. As of January 2012,there were 74 group leaders in the institute, 16 of them junior principalinvestigators. One of the general strengths of the CBMSO is the researchsupport services with competitive core equipment and technical expertise.These include a modern animal facility, optical and confocal microscopy,proteomics, bioinformatics and genomics (in this latter case, our centre leadsthe core facility for Madrid, at the UAM Scientific Park). In addition, we haveaccess within the institute to other specialized equipment and facilities,relevant for the execution of the proposed project: cell and virus culturefacilities (BSL2 and BSL3 labs), flow cytometry, electron microscopy andradioactivity labs with appropriate equipment and legal requirements.Additional support services include microbial fermentation, peptide synthesis,

  • 7/30/2019 Profile Analiza SWOT

    3/6

    graphic design, photography, computing services, library and administrativeservices (purchasing, personnel, institutional relations, cultural office, etc).

    My LINK

    Projects

    No projects provided

    Results

    No results provided

    Publications

    No publications provided

    News

    No news provided

    Other linksNo other links provided

    My LibraryEmpty

  • 7/30/2019 Profile Analiza SWOT

    4/6

    Main contactDr Simone GiannecchiniOrganisation name: University of FlorenceDepartment/Unit: Experimental and clinic medicineAddress: viale Morgagni 4850134 Florence Toscany ItalyTel: 39-055-4598524Fax: 39-055-4598924

    Main organisationUniversity of FlorenceDepartment: Public HealthPosition in organisation: full time researcherAddress: viale morgagni 48

    50134 Florence Toscany ItalyFavourite themeFP7-HEALTHExpertise descriptionHe has 15-years experience in cellular and molecular biology applied to thestudy of pathogenesis of viruses infections and their prevention. His maininterest is focused on the molecular mechanism of the immunopathogenesisof infection by viruses and on the antiviral development.Main research topics:Human Polyomavirus JCV: the interest of his research is focused on thestudy of molecular mechanisms of viral and cellular factors that may beinvolved in the reactivation of JCV in immunosuppressed patients and thatcan determine the beginning of the development of progressive multifocalleukoencephalopathy. In particular, he has studied the reactivation of JCV inpatients with immunomediated-diseases treated with the monoclonalantibody infliximab, monoclonal anti-TNFalpha used in clinical therapy. Inthese studies the correlation between the expression levels of cellularmicroRNAs and reactivation of JCV in the blood of the patients wasexamined. Recently, he has activated collaborations in order to study thereplicative activity of molecular clones of JCV carrying archetype or PML-prototype genomic structures.

    Influenza virus: he has performed its activities in studies on mechanisms ofpathogenesis of avian and human influenza viruses. In particular, the studieshave been projected to clarify the molecular mechanisms allow theinterspecies transmission of avian influenza virus correlating changes in theviral genome with phenotypic changes in their behaviour of changing thehost. In addition, another object of his interest are studies of anti-influenzavirus drugs. He has been involved on the investigation of the molecular basisof resistance to neuraminidase inhibitors such as oseltamivir and zanamivir

    https://cordis.europa.eu/partners/web/sgiannecchini/profile?p_p_id=3&p_p_lifecycle=0&p_p_state=maximized&p_p_mode=view&p_p_col_id=public-column-2&p_p_col_count=2&_3_orgName=University+of+Florence&_3_struts_action=%2Fsearch%2Fsearch&_3_searchtype=advSearchhttps://cordis.europa.eu/partners/web/sgiannecchini/profile?p_p_id=3&p_p_lifecycle=0&p_p_state=maximized&p_p_mode=view&p_p_col_id=public-column-2&p_p_col_count=2&_3_orgName=University+of+Florence&_3_struts_action=%2Fsearch%2Fsearch&_3_searchtype=advSearch
  • 7/30/2019 Profile Analiza SWOT

    5/6

    and the development of new antiviral. He demonstrated that nucleic acid-based molecules reproducing the packaging sequences of polymerase genescan be attractive new antiviral for the influenza virus. Several of his researchstudies have been done in collaboration with National or Internationalresearch groups (Istituto Superior di Sanit, Istituto zooprofilattico delle

    venezie, Roslin Institute of Edinburg).Expertise categoriesMedicine, Health, Biotechnology, Life sciencesSkills and competencesPresent position: Researcher in MED/07, Faculty of Medicine, University ofFlorence

    EducationDegree in Biological Sciences in 1993, University of Pisa.Professional qualification to Biologist in 1995, University of Pisa.PhD in "Immunobiology of Virus" in 1998, University of Pisa.Master in E-Medicine in 2006, University of Florence.From 2004 to 2006 time-dependent researcher, University of Florence.

    Scholarships, patents and awardsTwo-years post PhD fellowship in 1998, University of Pisa.ANLAIDS Scholarships in 2000 entitled to professor G.B. Rossi.Fellowships of the Istituto Superiore di Sanit in 2002.Patent Oligopeptides and their use in the pharmacological treatment of theFIV in the cat, HIPPOCAMPE S. A. (MYMETICS SA) deposited in France in2001.

    Award scientific entitled to Prof. Giovan Battista Rossi as a "Best YoungItalian Researcher for AIDS Studies" in 2002.

    He also participates actively in the virological surveillance of influenza,collaborating on this purpose to the national influenza center at the IstitutoSuperiore di Sanit, in the virology laboratory of the Department of PublicHealth who is the reference laboratory of the Tuscany region for thisactivity.He is member of society such as the Italian Society of Virology, the ItalianSociety of Medical Virology, the Italian Society of Microbiology, and theEuropean Society of Virology, and referee for several international journals.He is the author of 37 publications in extenso in journals with good impactfactor and a number of communications to national and international.

    Teaching activitiesUniversity lecturer of Microbiology and Clinical Microbiology in the three-year course of Dietician, of Phycical Therapy and Obstetrics at the Universityof Florence.

  • 7/30/2019 Profile Analiza SWOT

    6/6

    University lecturer of Microbiology and Clinical Virology, Microbiology andHygiene, Microbiology in the University three-year degree course ofBiotechnology, University of Florence.University lecturer of Applicative and experimental microbiology,Application of molecular virology, and Biotechnologies in microbiology, in

    the University master course of Biotechnology, University of Florence.Member of the teaching Committee of the PhD in Basic and clinic virology atthe University of Pisa.Research infrastructure of the organisationThe operative unit (OU) GIANNECCHINI has stable and strong researchinteractive collaborations with several researchers from differentinternational laboratories recognized of high importance. The infrastructureof the OU, located in the Department of Public Health, University of Florence,are composed of cellular and molecular biology laboratories includinglaboratory of recently set up of biosafety level 3. All research activities arecarried out with instruments available in the department and is composedmainly by thermocycler real-time PCR, Wester blot apparatus, thermostatsand other equipment to propagate cell cultures in vitro.

    My LINK

    Projects

    No projects provided

    Results

    No results provided

    Publications

    No publications provided

    News

    No news provided

    Other links

    No other links provided

    My LibraryEmpty